Gene (Official Symbol) | Gene name | Accession number | P value | Apert-to-control Ratio (Log2) | x-fold up-or down-regulated in Apert |
---|---|---|---|---|---|
Positive regulation of cell proliferation | |||||
CIP29 | cytokine induced protein 29 kDa | NM_033082.1 | 0.040 | 1.24 | 2.36 |
TCF19 | transcription factor 19 (SC1) | BC033086.1 | 0.041 | 1.23 | 2.34 |
SPBC25 b | spindle pole body component 25 homolog (S. cerevisiae) | NM_020675.3 | 0.010 | 1.18 | 2.27 |
STMN1 b | stathmin 1/oncoprotein 18 | NM_203401.1 | 0.006 | 1.11 | 2.16 |
SPAG5 b | sperm associated antigen 5 | NM_006461.2 | 0.007 | 0.98 | 1.97 |
MCM4 | MCM4 minichromosome maintenance deficient 4 (S. cerevisiae) | NM_182746.1 | 0.030 | 0.90 | 1.87 |
HCAP-G | chromosome condensation protein G | NM_022346.2 | 0.028 | 0.87 | 1.83 |
RRM2 b | ribonucleotide reductase M2 polypeptide | NM_001034.1 | 0.019 | 0.86 | 1.81 |
AURKB | aurora kinase B | NM_004217.1 | 0.031 | 0.84 | 1.79 |
NEK6 b | NIMA (never in mitosis gene a)-related kinase 6 | NM_014397.3 | 0.017 | 0.74 | 1.67 |
CKAP2 | cytoskeleton associated protein 2 | NM_018204.2 | 0.037 | 0.66 | 1.58 |
NEDD1 | neural precursor cell expressed, developmentally downregulated 1 | NM_152905.2 | 0.041 | 0.62 | 1.53 |
RNASEH2A b | ribonuclease H2, subunit A | NM_006397.2 | 0.011 | 0.60 | 1.52 |
UFD1L b | ubiquitin fusion degradation 1 like (yeast) | NM_005659.3 | 0.023 | 0.59 | 1.51 |
PLK3 | polo-like kinase 3 (Drosophila) | NM_004073.2 | 0.036 | 0.57 | 1.48 |
CKLF b | chemokine-like factor | NM_016951.2 | 0.021 | 0.55 | 1.46 |
TK1 | thymidine kinase 1, soluble | NM_003258.1 | 0.028 | 0.50 | 1.41 |
DTYMK | deoxythymidylate kinase | NM_012145.2 | 0.037 | 0.44 | 1.36 |
MUS81 b | MUS81 endonuclease homolog (S. cerevisiae) | NM_025128.3 | 0.024 | 0.44 | 1.35 |
MAPRE1 | microtubule-associated protein, RP/EB family, member 1 | NM_012325.1 | 0.045 | 0.38 | 1.30 |
HECA b | headcase homolog (Drosophila) | NM_016217.1 | 0.047 | −0.62 | 1.54 |
CSNK2A1 | casein kinase 2, α 1 polypeptide | NM_177560.2 | 0.030 | −0.73 | 1.66 |
BCL6 a | B-cell CLL/lymphoma 6 (zinc finger protein 51) | NM_001706.2 | 0.013 | −0.74 | 1.67 |
BCL3 | B-cell CLL/lymphoma 3 | NM_005178.2 | 0.039 | −0.79 | 1.73 |
ADAM33 | ADAM metallopeptidase domain 33 | NM_153202.1 | 0.027 | −1.22 | 2.33 |
PDGFRA | platelet-derived growth factor receptor, α polypeptide | NM_006206.2 | 0.045 | −1.34 | 2.53 |
ChGn a | chondroitin beta1,4 N-acetylgalactosaminyltransferase | NM_018371.3 | 0.015 | −1.42 | 2.68 |
PIK3C2B a | phosphoinositide-3-kinase, class 2, β polypeptide | NM_002646.2 | 0.004 | −1.54 | 2.91 |
Negative regulation of cell proliferation | |||||
RAD1 b | RAD1 homolog (S. pombe) | NM_002853.2 | 0.018 | 0.73 | 1.66 |
CDKN3 | cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) | NM_005192.2 | 0.044 | 0.60 | 1.52 |
RBM5 b | RNA binding motif protein 5 | NM_005778.1 | 0.024 | −0.69 | 1.61 |
ING4 | inhibitor of growth family, member 4 | NM_198287.1 | 0.044 | −0.69 | 1.62 |
IFITM3 | interferon induced transmembrane protein 3 (1-8U) | NM_021034.1 | 0.033 | −0.83 | 1.77 |
KLF11 | Kruppel-like factor 11 | NM_003597.4 | 0.039 | −0.92 | 1.89 |
MTSS1 b | metastasis suppressor 1 | NM_014751.2 | 0.009 | −1.14 | 2.20 |
RARRES3 b | retinoic acid receptor responder (tazarotene induced) 3 | NM_004585.2 | 0.022 | −1.64 | 3.12 |
Nucleotide metabolism | |||||
CTPS | CTP synthase | NM_001905.1 | 0.046 | 0.98 | 1.98 |
RRM2 b | ribonucleotide reductase M2 polypeptide | NM_001034.1 | 0.019 | 0.86 | 1.81 |
PRPS1L1 b | phosphoribosyl pyrophosphate synthetase 1-like 1 | NM_175886.2 | 0.022 | 0.71 | 1.63 |
POLR3K b | polymerase (RNA) III (DNA directed) polypeptide K | NM_016310.2 | 0.013 | 0.69 | 1.61 |
RRM1 | ribonucleotide reductase M1 polypeptide | NM_001033.2 | 0.045 | 0.55 | 1.46 |
TK1 | thymidine kinase 1, soluble | NM_003258.1 | 0.028 | 0.50 | 1.41 |
DTYMK | deoxythymidylate kinase | NM_012145.2 | 0.037 | 0.44 | 1.36 |
ADCY2 b | adenylate cyclase 2 (brain) | NM_020546.1 | 0.028 | 0.41 | 1.33 |
ATP5G1 | ATP synthase, H + transporting, mitochondrial F0 complex, subunit C1 (subunit 9) | NM_005175.1 | 0.042 | 0.28 | 1.22 |
PDE6G b | phosphodiesterase 6G, cGMP-specific, rod, gamma | NM_002602.1 | 0.003 | −0.53 | 1.44 |
Regulation of gene expression | |||||
CIP29 | cytokine induced protein 29 kDa | NM_033082.1 | 0.040 | 1.24 | 2.36 |
ZNF738 a | zinc finger protein 738 | BC034499.1 | 0.003 | 1.03 | 2.04 |
POLR3K b | polymerase (RNA) III (DNA directed) polypeptide K | NM_016310.2 | 0.013 | 0.69 | 1.61 |
ELAVL1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) | NM_001419.2 | 0.041 | 0.67 | 1.59 |
HIP2 b | huntingtin interacting protein 2 | NM_005339.3 | 0.017 | 0.58 | 1.49 |
CREB3 b | cAMP responsive element binding protein 3 | NM_006368.4 | 0.023 | 0.46 | 1.38 |
CASP8AP2 | CASP8 associated protein 2 | NM_012115.2 | 0.049 | 0.41 | 1.33 |
ZNF414 b | zinc finger protein 414 | NM_032370.1 | 0.029 | 0.41 | 1.32 |
GABPB2 | GA binding protein transcription factor, β subunit 2 | NM_002041.2 | 0.027 | 0.40 | 1.32 |
SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | NM_003072.2 | 0.034 | 0.39 | 1.31 |
SIX5 b | sine oculis homeobox homolog 5 (Drosophila) | NM_175875.3 | 0.017 | −0.49 | 1.40 |
ZNF44 | zinc finger protein 44 | BC032246.1 | 0.032 | −0.57 | 1.49 |
ZFHX4 | zinc finger homeodomain 4 | NM_024721.2 | 0.030 | −0.58 | 1.49 |
MITF | microphthalmia-associated transcription factor | NM_006722.1 | 0.042 | −0.60 | 1.51 |
ZNF688 | zinc finger protein 688 | NM_145271.2 | 0.026 | −0.61 | 1.53 |
TNIP2 b | TNFAIP3 interacting protein 2 | NM_024309.2 | 0.008 | −0.62 | 1.54 |
ING4 | inhibitor of growth family, member 4 | NM_198287.1 | 0.044 | −0.69 | 1.62 |
BCL6 a | B-cell CLL/lymphoma 6 (zinc finger protein 51) | NM_001706.2 | 0.013 | −0.74 | 1.67 |
ELL3 b | elongation factor RNA polymerase II-like 3 | NM_025165.1 | 0.006 | −0.74 | 1.67 |
PPARA b | peroxisome proliferative activated receptor, α | NM_032644.1 | 0.009 | −0.74 | 1.67 |
RELB | v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (avian) | NM_006509.2 | 0.033 | −0.74 | 1.67 |
ZFP64 b | zinc finger protein 64 homolog (mouse) | NM_018197.2 | 0.017 | −0.78 | 1.72 |
BCL3 | B-cell CLL/lymphoma 3 | NM_005178.2 | 0.039 | −0.79 | 1.73 |
NFIL3 b | nuclear factor, interleukin 3 regulated | NM_005384.1 | 0.012 | −0.83 | 1.77 |
ANKZF1 | ankyrin repeat and zinc finger domain containing 1 | NM_018089.1 | 0.036 | −0.85 | 1.81 |
ARID5A | AT rich interactive domain 5A (MRF1-like) | NM_006673.2 | 0.042 | −0.92 | 1.89 |
KLF11 | Kruppel-like factor 11 | NM_003597.4 | 0.039 | −0.92 | 1.89 |
CREB5 b | cAMP responsive element binding protein 5 | NM_004904.1 | 0.010 | −1.00 | 2.00 |
PNRC1 a | proline-rich nuclear receptor coactivator 1 | NM_006813.1 | 0.008 | −1.05 | 2.07 |
ATF3 | activating transcription factor 3 | NM_004024.2 | 0.049 | −1.10 | 2.14 |
MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | NM_005360.2 | 0.044 | −1.19 | 2.29 |
ZNF385 b | zinc finger protein 385 | NM_015481.1 | 0.011 | −1.38 | 2.61 |
Cell Adhesion | |||||
HAPLN1 a | hyaluronan and proteoglycan link protein 1 | NM_001884.2 | 0.005 | 3.00 | 7.99 |
CIB1 b | calcium and integrin binding 1 (calmyrin) | NM_006384.2 | 0.035 | 0.32 | 1.25 |
FLRT2 | fibronectin leucine rich transmembrane protein 2 | NM_013231.3 | 0.042 | −0.64 | 1.56 |
CNTNAP1 | contactin associated protein 1 | NM_003632.1 | 0.041 | −0.72 | 1.64 |
CSNK2A1 | casein kinase 2, α 1 polypeptide | NM_177560.2 | 0.030 | −0.73 | 1.66 |
LGALS3BP b | lectin, galactoside-binding, soluble, 3 binding protein | NM_005567.2 | 0.014 | −0.89 | 1.85 |
PERP | PERP, TP53 apoptosis effector | NM_022121.2 | 0.042 | −0.92 | 1.89 |
ADAM8 b | a disintegrin and metalloproteinase domain 8 | NM_001109.1 | 0.044 | −1.06 | 2.08 |
CLDN15 b | claudin 15 | NM_014343.1 | 0.022 | −1.13 | 2.19 |
ADAM33 | ADAM metallopeptidase domain 33 | NM_153202.1 | 0.027 | −1.22 | 2.33 |
PDGFRA | platelet-derived growth factor receptor, α polypeptide | NM_006206.2 | 0.045 | −1.34 | 2.53 |
TNXB b | tenascin XB | NM_032470.2 | 0.015 | −2.32 | 4.98 |
DKFZp434 B1231 b | eEF1A2 binding protein | NM_178275.3 | 0.010 | −2.66 | 6.31 |
Extracellular matrix component, biosynthesis | |||||
HAPLN1 a | hyaluronan and proteoglycan link protein 1 | NM_001884.2 | 0.005 | 3.00 | 7.99 |
TIMP3 a | TIMP metallopeptidase inhibitor 3 | BG104808.1 | 0.006 | 0.42 | 1.34 |
BMP1 b | bone morphogenetic protein 1 | NM_006129.2 | 0.024 | −0.62 | 1.54 |
B4GALT7 b | xylosylprotein β 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) | NM_007255.1 | 0.026 | −0.66 | 1.57 |
MATN2 | matrilin 2 | NM_030583.1 | 0.027 | −0.96 | 1.95 |
ChGn a | chondroitin beta1,4 N-acetylgalactosaminyltransferase | NM_018371.3 | 0.015 | −1.42 | 2.68 |
TNXB b | tenascin XB | NM_032470.2 | 0.015 | −2.32 | 4.98 |
MAPK signaling pathway | |||||
DUSP2 b | dual specificity phosphatase 2 | NM_004418.2 | 0.004 | 1.17 | 2.25 |
STMN1 b | stathmin 1/oncoprotein 18 | NM_203401.1 | 0.006 | 1.11 | 2.16 |
PLA2G12A | phospholipase A2, group XIIA | NM_030821.3 | 0.044 | 0.39 | 1.31 |
PDE6G b | phosphodiesterase 6G, cGMP-specific, rod, gamma | NM_002602.1 | 0.003 | −0.53 | 1.44 |
TNIP2 b | TNFAIP3 interacting protein 2 | NM_024309.2 | 0.008 | −0.62 | 1.54 |
UCN | urocortin | NM_003353.2 | 0.044 | −0.65 | 1.57 |
CASP7 b | caspase 7, apoptosis-related cysteine peptidase | NM_001227.2 | 0.023 | −0.65 | 1.57 |
MAP3K6 | mitogen-activated protein kinase kinase kinase 6 | NM_004672.3 | 0.041 | −0.67 | 1.59 |
BCL3 | B-cell CLL/lymphoma 3 | NM_005178.2 | 0.039 | −0.79 | 1.73 |
MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | NM_005456.2 | 0.037 | −0.86 | 1.81 |
SPTBN1 | spectrin, beta, non-erythrocytic 1 (SPTBN1) | NM_003128.1 | 0.049 | −0.87 | 1.83 |
KLF11 | Kruppel-like factor 11 | NM_003597.4 | 0.039 | −0.92 | 1.89 |
PNRC1 a | proline-rich nuclear receptor coactivator 1 | NM_006813.1 | 0.008 | −1.05 | 2.07 |
PDGFRA | platelet-derived growth factor receptor, α polypeptide | NM_006206.2 | 0.045 | −1.34 | 2.53 |
PIK3C2B a | phosphoinositide-3-kinase, class 2, β polypeptide | NM_002646.2 | 0.004 | −1.54 | 2.91 |
RARRES3 b | retinoic acid receptor responder (tazarotene induced) 3 | NM_004585.2 | 0.022 | −1.64 | 3.12 |